First Time Loading...

SeQuent Scientific Ltd
NSE:SEQUENT

Watchlist Manager
SeQuent Scientific Ltd Logo
SeQuent Scientific Ltd
NSE:SEQUENT
Watchlist
Price: 121.15 INR -0.94% Market Closed
Updated: May 5, 2024
Section:
 

Wall Street
Price Targets

SEQUENT Price Targets Summary
SeQuent Scientific Ltd

Wall Street analysts forecast SEQUENT stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for SEQUENT is 133.5 INR .

SEQUENT Lowest Forecast
Wall Street Target
Not Available
SEQUENT Average Forecast
Wall Street Target
133.5 INR
10% Upside
SEQUENT Highest Forecast
Wall Street Target
Not Available
Lowest
Price Target
Not Available
Average
Price Target
133.5 INR
10% Upside
Highest
Price Target
Not Available
SeQuent Scientific Ltd Competitors:
Price Targets
DERM
Journey Medical Corp
117% Upside
300723
Yipinhong Pharmaceutical Co Ltd
47% Upside
CURA
Curaleaf Holdings Inc
36% Upside
A
ABBOTINDIA
Abbott India Ltd
12% Upside
DERM
Journey Medical Corp
117% Upside
300723
Yipinhong Pharmaceutical Co Ltd
47% Upside
CURA
Curaleaf Holdings Inc
36% Upside
A
ABBOTINDIA
Abbott India Ltd
12% Upside
4503
Astellas Pharma Inc
33% Upside
002349
Jinghua Pharmaceutical Group Co Ltd
293% Upside
A
AHEALTH
Apex Healthcare Bhd
21% Downside
326030
SK Biopharmaceuticals Co Ltd
29% Upside

Revenue
Forecast

Revenue Estimate
SeQuent Scientific Ltd

For the last 8 years the compound annual growth rate for SeQuent Scientific Ltd's revenue is 16%. The projected CAGR for the next 1 year is 3%.

16%
Past Growth
3%
Estimated Growth
Estimates Accuracy
-3%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
SeQuent Scientific Ltd

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
SeQuent Scientific Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-17%
Average Miss
What are analyst estimates?

See Also

Summary
SEQUENT intrinsic value, competitors valuation, and company profile.
DCF Valuation
SEQUENT stock valuation using Discount Cash Flow valuation method.
Relative Valuation
SEQUENT stock valuation using valuation multiples.
Wall Street Estimates
SEQUENT price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
SEQUENT stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is SEQUENT's stock price target?
Price Target
133.5 INR

According to Wall Street analysts, the average 1-year price target for SEQUENT is 133.5 INR .

What is SeQuent Scientific Ltd's Revenue forecast?
Projected CAGR
3%

For the last 8 years the compound annual growth rate for SeQuent Scientific Ltd's revenue is 16%. The projected CAGR for the next 1 year is 3%.

ALPHA SPREAD
Join more than 134,300+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.